Bleakley Financial Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,456
Closed -$887K 986
2023
Q3
$887K Sell
4,456
-125
-3% -$29.6K 0.03% 403
2023
Q2
$1.31M Sell
4,581
-2,295
-33% -$637K 0.04% 347
2023
Q1
$1.49M Buy
+6,876
New +$1.34M 0.05% 316

Other funds holding SWAV

Bleakley Financial Group's SWAV Position: Q4 2023 in Review

Bleakley Financial Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 4,456 shares — an estimated $887K sold.

Bleakley Financial Group first reported a position in SWAV in Q1 2023 and held it in 3 quarters. The position peaked at $1.49M in Q1 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Bleakley Financial Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bleakley Financial Group sold 4,456 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $887K.
  • Bleakley Financial Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Bleakley Financial Group's Shockwave Medical, Inc. Common Stock position peaked at $1.49M in Q1 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Bleakley Financial Group's 13F filing for Q4 2023, filed 25 Jan 2024.